|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Caregivers, 91 Categories of recommended HIV disability allowances in report, x–xii HIV-associated conditions without Listings in other body systems, xi HIV-associated diseases with existing Listings elsewhere, xi–xii imminently fatal conditions, xi CD4 cell count, 34, 47–49, 113, 129 indicating disease progression, 45–50 as an indicator of disability, x–xi, 6–7, 45–52 progression of untreated HIV infection demonstrated by, 46 Centers for Disease Control and Prevention (CDC), x, 1, 15, 29, 33, 47, 82, 96, 105 Central nervous system (CNS), lymphomas arising within, 56, 82, 148 Cervical cancer, invasive, 82 Children, defining, 2n Children with HIV/AIDS concepts specific to, x, 10–12, 87–99, 131–132 mood disorders, with HIV, 91 proposed disabling CD4 count ranges for children, 11 rationale for listing recommendations for pediatric patients, 92–96 specialized evaluation of cases involving, 21 Children with HIV Early Antiretroviral Therapy trial, 90 Chronic conditions associated with aging, 15 Chronic diarrhea, defining, 66 Chronic hepatitis, 81 Chronic inflammatory state, associated with HIV infection, 33, 78 Chronic kidney disease including HIV-associated nephropathy, 79–80 an increasing problem for the HIV-infected, xi Cirrhosis of the liver, 81 Collagen-vascular diseases, 81 Combined antiretroviral therapy. See Antiretroviral therapy Committee on Social Security HIV Disability Criteria, 1–2, 29–31 considerations for developing a Listing, 30 Comorbidities of HIV, 9, 34–35 behavioral disorders, 35 cognitive dysfunction, 35 cognitive limitations, 34-35, 103 delirium, 35 drug dependence, 35 major depressive disorder, 34 posttraumatic stress disorder, 35 psychiatric disorders, 35 substance abuse, 34 Composite International Diagnostic Interview, 28 Concurrent conditions, 63 Conditions covered elsewhere in the Listings, 10, 77–84 cardiovascular disease, 10, 78–79, 84 chronic kidney disease, including HIV-associated nephropathy, 10, 79–80, 84 malignancies not otherwise specified, 10, 82–84 Conditions currently without Listings, 9, 64–74 distal sensory polyneuropathy, 9, 64, 66–67, 74 HIV-associated neurocognitive disorders (HAND), 9, 64, 67–69, 74 HIV-associated wasting syndrome, 9, 64, 69–70, 74, 123 Kaposi’s sarcoma, 9, 64, 70–71, 74 lipoatrophy and lipohypertrophy, 9, 64, 71–72, 74 Contrast-enhanced computed tomography (CT), 56, 72 “Controlling weight,” applied to treating source opinions, 22 Cross-referencing procedure in the SSA, 77, 83–84 Curcumin, 66 Current concepts in HIV/AIDS, 33–43 evolution of the epidemic, 33–36 improvements in functioning and capacity to return to work, 39–41
|
|
|||||||||||||||
